The amino-terminus of the amyloid-β protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages

Journal of Neuroimmunology

Volumn 96, Issue 1, 1999, Pages 121-130

  Van Muiswinkel, Freek L ^a   Raupp, Sigrid F A ^b   De Vos, N Machiel ^b   Smits, Hessel A ^b   Verhoef, Jan ^b   Eikelenboom, Piet ^a   Nottet, Hans S L M ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alzheimer's disease; Amyloid peptide; Chemiluminescence; Flow cytometry; Human macrophages; Respiratory burst activity

Indexed keywords

AMYLOID BETA PROTEIN; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BINDING, COMPETITIVE; BRAIN CHEMISTRY; CHEMILUMINESCENT MEASUREMENTS; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; MACROPHAGES; MONOCYTES; PEPTIDE FRAGMENTS; PROTEIN BINDING; RESPIRATORY BURST; SUPEROXIDES;

EID: 0033118464     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00019-3     Document Type: Article

References (47)

1. Ard M.D., Cole G.M., Wei J., Mehrle A.P., Fratkin J.D. Scavenging of Alzheimer's amyloid-β protein by microglia in culture. J. Neurosci. Res. 43:1996;190-202.
2. Chao C.C., Hu S., Peterson P.K. Modulation of human microglial cell superoxide production by cytokines. J. Leukocyte Biol. 58:1995;65-70.
3. Colton, C., Gilbert, D.L., 1993. Microglia, an in vivo source of reactive oxygen species in the brain. In: Seil, F.J. (Ed.), Advances in Neurology, Vol. 59, Neuronal Injury and Regeneration. Raven Press, New York, pp. 321-326.
4. Colton C., Wilt S., Gilbert D., Chernyshev O., Snell J., Dubois-Dalcq M. Species differences in the generation of reactive oxygen species by microglia. Mol. Chem. Neuropathol. 28:1996;15-20.
5. Dickson D.W. The pathogenesis of senile plaques. J. Neuropath. Exp. Neurol. 56:1997;321-339.
6. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.C., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
7. Eikelenboom P., Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 17:1996;673-680.
8. Eikelenboom P., Rozemuller J.M., Kraal G., Stam F.C., McBride P.A., Bruce M.E., Fraser H. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch. B: Cell Pathol. Mol. Pathol. 60:1991;329-331.
9. Eikelenboom P., Zhan S.S., Van Gool W.A., Allsop D. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15:1994;447-450.
10. El Khoury J., Hickmann S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
11. Giulian, D., 1997. Immune responses and dementia. In: Reis, D.J., Posner, J.B. (Eds.), Annals of the New York Academy of Sciences, Vol. 835, Frontiers of Neurology: A Symposium In Honor Of Fred Plum. The NY Acad. Sci., New York, NY, pp. 91-110.
12. Giulian D., Haverkamp L.J., Li J., Karshin W.L., Yu J., Tom D., Li X., Kirkpatrick J.B. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27:1995;119-137.
13. Giulian D., Haverkamp L.J., Yu J.H., Karshin W., Tom D., Li J., Kirkpatrick J., Kuo Y.-M., Roher A.E. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16:1996;6021-6037.
14. Gyllenhammar H. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J. Immunol. Meth. 97:1987;209-213.
15. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
16. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
17. Haga S., Ikeda K., Sato M., Ishii T. Synthetic alzheimer amyloid-β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601:1993;88-94.
18. Hu J., Akama K.T., Krafft G., Chromy B.A., Van Eldik L.J. Amyloid-β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785:1998;195-206.
19. Kaltschmidt B., Uherek M., Volk B., Baeurle P.A., Kaltschmidt C. Transcription factor NF-κB is activated in primary neurons by amyloid-β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2642-2647.
20. Klegeris A., McGeer P.L. β-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res. 49:1997;229-235.
21. Klegeris A., Walker D.G., McGeer P.L. Activation of macrophages by Alzheimer β-amyloid peptide. Biochem. Biophys. Res. Commun. 199:1994;984-991.
22. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A. Diffusible, non-fibrillar ligands derived from Aβ(1-42) are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. 95:1998;6448-6453.
23. London J.A., Biegel D., Pachter J.S. Neurocytopathic effects of β-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 93:1996;4147-4152.
24. Lorton D. Beta-amyloid-induced IL-1β release from an activated human monocyte cell line is calcium- and G-protein-dependent. Mech. Ageing Dev. 94:1997;199-211.
25. Lorton D., Kocsis J.-M., King L., Madden K., Brunden K.R. β-amyloid induces increased release of interleukin-1β from lipopolysaccharide-activated human monocytes. J. Neuroimmunol. 67:1996;21-29.
26. McDonald D.R., Brunden K.R., Landreth G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17:1997;2284-2294.
27. Meda L., Cassatella M.A., Szendrei G.I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ Nature. 374:1995;647-650.
28. Meda L., Bonaiuto C., Szendrei G.I., Ceska M., Rossi F., Cassatella M.A. β-amyloid (25-35) induces the production of interleukin-8 from human monocytes. J. Neuroimmunol. 59:1995;29-33.
29. Meda L., Bernasconi S., Bonaiuto C., Sozzani S., Zhou D., Otvos L. Jr., Mantovani A., Rossi F., Cassatella M.A. β-amyloid (25-35) peptide and IFN-γ synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J. Immunol. 157:1996;1213-1218.
30. Meda L., Bonaiuto C., Baron P., Otvos L. Jr., Rossi F., Cassatella M.A. Priming of monocyte respiratory burst by β-amyloid fragment (25-35). Neurosci. Lett. 219:1996;91-94.
31. Nottet H.S.L.M., Gendelman H.E. Unraveling the neuroimmune mechanisms for the HIV-1 associated cognitive/motor complex. Immunol. Today. 16:1995;441-448.
32. Nottet H.S.L.M., de Graaf L., de Vos N.M., Bakker L., van Strijp J.A.G., Visser M.R., Verhoef J. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J. Infect. Dis. 168:1993;84-91.
33. Nottet H.S.L.M., Jett M., Flanagan C.R., Zhai Q.H., Persidsky Y., Rizzino A., Bernton E.W., Genis P., Baldwin T., Schwartz J., LaBenz C., Gendelman H.E. A regulatory role for astrocytes in HIV-1 encephalitis: an overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-α by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154:1995;3567-3581.
34. O'Neill L.A.J., Kaltschmidt C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:1997;252-258.
35. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid-β protein via a scavenger receptor. Neuron. 17:1996;553-565.
36. Popko B., Corbin J.G., Baerwald K.D., Dupree J., Garcia A.M. The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 14:1997;19-35.
37. Selkoe D.J. Amyloid-β protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
38. Tjernberg L.O., Näslund J., Lindqvist F., Johanson J., Karlström A.R., Thyberg J., Terenius L., Nordstedt C. Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271:1996;8545-8548.
39. Ulvestad E., Williams K., Bjerkvig R., Tiekotter K., Antel J., Matre R. Human microglia cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J. Leukocyte Biol. 56:1994;732-740.
40. Van Muiswinkel F.L., Eikelenboom P. Do non-steroidal anti-inflammatory drugs (NSAIDs) have a protective effect against dementia? Drugs and Aging. 9:1996;1-7.
41. Van Muiswinkel, F.L., Eikelenboom, P., 1998. Inflammation and oxidative stress in Alzheimer's disease. In: Cacabelos, R., Winblad, B., Eikelenboom, P., (Eds.), Neurogerontology and Neurogeriatrics, Vol. 2. Prous Science, Barcelona, pp. 43-55.
42. Van Muiswinkel F.L., Veerhuis R., Eikelenboom P. Amyloid-β protein (Aβ) primes cultured rat microglial cells for an enhanced phorbol-myristate-acetate-induced respiratory burst activity. J. Neurochem. 66:1996;2468-2476.
43. Van Muiswinkel F.L., Azizeh B.Y., Tenner A.J., Cribbs D.H., Cotman C.W. Non-fibrillar β-amyloid is capable of priming the respiratory burst activity of rat microglial cells and human monocytes. Soc. Neurosci. Abstr. 23:1997;6358.
44. Velazques P., Cribbs D.H., Poulos T.L., Tenner A.J. Aspartate residue 7 in amyloid-β protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis. Nat. Med. 3:1997;77-79.
45. Vitek M.P., Snell J., Dawson H., Colton C.A. Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochem. Biophys. Res. Commun. 240:1997;391-394.
46. Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Godman G.C., Nawroth P., Zweier J.L., Stern D. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid-β peptide. Nat. Med. 7:1995;693-699.
47. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.